Human translational studies investigating the neurocognitive effects of 5-HT4 receptor agonism
<p>Major depression is common, costly, and a global cause of significant morbidity. First-line antidepressant medication has a clinically problematic delay before therapeutic efficacy and is ineffective for a subset of those affected. In addition, many patients with depression, as well as othe...
Autor principal: | De Cates, AN |
---|---|
Outros Autores: | Harmer, C |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
2022
|
Assuntos: |
Registos relacionados
-
The role of the 5-HT2C receptor in emotional processing in healthy adults
Por: Rawlings, N
Publicado em: (2010) -
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review
Por: Kyle Arsenault‐Mehta, et al.
Publicado em: (2024-03-01) -
Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression
Por: Severus Emanuel, et al.
Publicado em: (2012-07-01) -
Towards a neurocognitive understanding of angiotensin-II receptor blockade: insights into memory, stress, and their implications for PTSD
Por: Shkreli, L
Publicado em: (2024) -
Role of oxytocin in modulating addictive behaviour
Por: P. Bach, et al.
Publicado em: (2021-04-01)